annb0t
Top 20
Wall Street analysts forecast that ResMed (RMD) will report quarterly earnings of $2.36 per share in its upcoming release, pointing to a year-over-year increase of 10.8%. It is anticipated that revenues will amount to $1.28 billion, exhibiting an increase of 7.3% compared to the year-ago quarter.
The consensus EPS estimate for the quarter has been revised 0.1% lower over the last 30 days to the current level. This reflects how the analysts covering the stock have collectively reevaluated their ...
>>> Read more: What Analyst Projections for Key Metrics Reveal About ResMed (RMD) Q3 Earnings
The consensus EPS estimate for the quarter has been revised 0.1% lower over the last 30 days to the current level. This reflects how the analysts covering the stock have collectively reevaluated their ...
>>> Read more: What Analyst Projections for Key Metrics Reveal About ResMed (RMD) Q3 Earnings
